“Ben impresses me as one of the hardest-working, most intelligent and capable colleagues I have encountered in my career. Ben is assertive, well-spoken, and strikes the perfect balance of being a visionary and having a keen sense of reality. Having worked with him at companies where he is Head of Medical Affairs, I find that his greatest asset is his strategic thinking and ability to navigate through seemingly unsurmountable challenges, while always maintaining a positive attitude. His people skills are unmatched, communicating effectively and effortlessly with key thought leaders, management, and staff alike. I firmly believe that Ben would be a huge asset for any company and give him my strongest recommendation!”
Ben Cadieux
Los Angeles, California, United States
1K followers
500+ connections
Los Angeles, California, United States
1K followers
500+ connections
About
Experienced Vice President Medical Affairs with a demonstrated history of working in the…
Activity
-
Friends and colleagues, There has been an amazing evolution of genetic intervention for lifelong disorders. One such disease is #Fragile X syndrome,…
Friends and colleagues, There has been an amazing evolution of genetic intervention for lifelong disorders. One such disease is #Fragile X syndrome,…
Liked by Ben Cadieux
-
Happy #IndependeceDay from all of us at MEI. Wishing everyone a fun & safe #4thOfJuly!
Happy #IndependeceDay from all of us at MEI. Wishing everyone a fun & safe #4thOfJuly!
Liked by Ben Cadieux
-
We are excited to share this news today, and look forward to creating a site that will manufacture #lifechanging medicines! #nc #biomanufacturing
We are excited to share this news today, and look forward to creating a site that will manufacture #lifechanging medicines! #nc #biomanufacturing
Liked by Ben Cadieux
Experience
Education
Licenses & Certifications
Recommendations received
1 person has recommended Ben
Join now to viewMore activity by Ben
-
We are pleased to share the FDA has selected DNL126 (ETV:SGSH), an investigational treatment for MPS IIIA (Sanfilippo syndrome Type A), for…
We are pleased to share the FDA has selected DNL126 (ETV:SGSH), an investigational treatment for MPS IIIA (Sanfilippo syndrome Type A), for…
Liked by Ben Cadieux
-
Board Chair Ronald D. Lewis, II, Ph.D., was on FOX 5 San Diego (KSWB-TV) today to discuss the U.S. Food and Drug Administration (FDA) advisory…
Board Chair Ronald D. Lewis, II, Ph.D., was on FOX 5 San Diego (KSWB-TV) today to discuss the U.S. Food and Drug Administration (FDA) advisory…
Liked by Ben Cadieux
-
Preventative health is a personal interest and critical part of what the future of health needs. I'm excited to speak with Julia Hawkins, Dr. Daniel…
Preventative health is a personal interest and critical part of what the future of health needs. I'm excited to speak with Julia Hawkins, Dr. Daniel…
Liked by Ben Cadieux
People also viewed
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Ben Cadieux
-
Ben Cadieux
-
Benjamin Cadieux
-
Benjamin Cadieux
--
-
Benjamin Cadieux
Student at Arizona State University
4 others named Ben Cadieux are on LinkedIn
See others named Ben Cadieux